Alert detail
FDA Approval: OXYCONTIN (OXYCODONE HYDROCHLORIDE) — Type 5 - New Formulation or New Manufacturer
Policy ID: FDA-NDA022272Specialty: Pain ManagementAdded: 6/23/2026Effective: 2010-04-05federal register
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.